Share this page:

News

Swift Launches Accel-Amplicon™ Custom NGS Panels, Accelerating Variant Discovery in Challenging Biological Samples

Genialis/Swift partnership delivers a complete targeted sequencing solution with intuitive analysis software (ANN ARBOR, Mich. – Oct. 12, 2017) Swift Biosciences, a leading provider of innovative library prep solutions for next-generation sequencing (NGS), today announced the launch of its Accel-Amplicon™ Custom NGS Panels. These new panels offer a targeted DNA sequencing product that enables clinical researchers

More »

Swift Biosciences Growth Sparks Expansion into New Headquarters & First West Coast Office

Michigan company doubles size of Ann Arbor-based operations and expands to San Francisco with new commercial office space (ANN ARBOR, Mich. and SOUTH SAN FRANCISCO – October 5, 2017) Swift Biosciences, a leading provider of innovative library-prep solutions for genomic sequencing, today announced the move and expansion of their headquarters in Ann Arbor, Michigan, and the

More »

Swift Announces the Highest Throughput Single-Cell Methyl-Seq Library Preparation Method

Study published in Science magazine demonstrates how epigenetic markers can identify cell subtypes and regulatory elements that drive cellular diversity (ANN ARBOR, Mich. – August 10, 2017) Swift Biosciences, a leading provider of innovative library prep solutions for next-generation sequencing (NGS), today announced the launch of a new single-cell methylation sequencing method based on its Accel-NGS®

More »

Swift Biosciences Announces New Industry-Leading Indexed Adapters for Sequencing Larger Numbers of Samples in a Single Run

Revolutionary technology will accelerate utility of gene mapping, biomarker discovery, tumor profiling, and liquid biopsy analysis. Swift Biosciences, a leading provider of innovative library prep solutions for genomic sequencing, today announced the launch of Accel-NGS® 2S Indexed Adapters, a new portfolio of indices that significantly improves multiplexed next-generation

More »

Swift Biosciences Launches Next Phase of Company Growth and Expansion

Company completes Series D funding and adds two new directors to board. Swift Biosciences, a leading provider of innovative library prep solutions for genomic sequencing, today announced the completion of a Series D funding raise of $12.2 million. The company also announced the addition of two new directors to its board, positioning the company for accelerated growth. The Series D round was led by Arboretum Ventures

More »

Swift Biosciences Launches New Assay for Faster, More Efficient Routine Screening of the CFTR Gene

Accel-Amplicon™ CFTR Panel presented at the 2017 American College of Medical Genetics Annual Meeting – Swift Biosciences today announced the commercial release of its Accel-Amplicon CFTR Panel. This panel will offer research laboratories a more comprehensive, next-generation sequencing (NGS)-based approach to interrogate the coding region and select introns within the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR)

More »

Swift Biosciences Launches Novel Long-Insert Library Kit to Improve Data Quality on Pacific Biosciences® Sequencing Platforms

Results from Mount Sinai, Washington University, and Cold Spring Harbor Laboratories to be presented at AGBT 2017 General Meeting (ANN ARBOR, Mich. – February 14, 2017) Swift Biosciences today announced the commercial release of its Accel-NGS® XL Library Prep Kit, the fastest sequencing solution for whole genome sequencing on Pacific Biosciences (PacBio®) platforms. This library preparation

More »

Swift Biosciences Expands Team, Hires Vice President of Marketing

Ann Arbor, MI, February 8, 2017 – Swift Biosciences, today announced that it has hired Candia Brown as Vice President of Global Marketing. Brown brings over 25 years of biotechnology experience including product development, product management and market development. “Candia‘s deep expertise in the genomic tools market and associated applications coupled to her incredibly strong track

More »

Endometrial Cancer Mutations Are Detectable in Uterine Lavage Fluid Before a Cancer Is Diagnosed

NEW YORK, NY – December 27, 2016 /Press Release/ – Mutations that have been linked to endometrial cancer can be found in the uterine lavage fluid of pre- and post-menopausal women both with and without detectable cancer, according to a study published in PLOS Medicine by John Martignetti, MD, PhD of the Icahn School of Medicine

More »

View Swift Biosciences Corporate Workshops from AMP 2016

Ann Arbor, MI, December 7, 2016 – Swift Biosciences held two highly regarded Corporate Workshops at the AMP 2016 Annual Meeting (Nov 9, 2016, Charlotte, NC) highlighting the use of NGS technologies for FFPE and liquid biopsy samples. Industry-leading speakers presented on Swift’s behalf. View all presentations. Maximizing the Potential of FFPE Samples with Targeted NGS

More »